Litcius/Paper detail

cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons

Yo Sasaki, Thomas M. Engber, Robert Hughes, Matthew D. Figley, Tong Wu, Todd Bosanac, Rajesh Devraj, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio

2020Experimental Neurology125 citationsDOIOpen Access PDF

Topics & Concepts

AxotomyAxonDegeneration (medical)PathologicalBiomarkerMedicineAxonal degenerationNeuroscienceNeuropathologyNeuroprotectionPathologyCentral nervous systemBiologyDiseaseBiochemistryCalcium signaling and nucleotide metabolismSirtuins and Resveratrol in MedicineSignaling Pathways in Disease
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons | Litcius